Published in Clin Exp Immunol on December 01, 1976
Precise standardization of reagents for complement fixation. Am J Trop Med Hyg (1963) 6.54
Immunoglobulins on the surface of human lymphocytes. Lancet (1971) 5.25
Studies on mediator production by highly purified human T and B lymphocytes. J Exp Med (1974) 3.38
IN-VITRO STUDIES OF LYMPHOCYTES FROM PATIENTS WITH SARCOIDOSIS AND LYMPHOPROLIFERATIVE DISEASES. Lancet (1964) 2.86
Selective gamma-g globulin deficiencies in patients with recurrent pyogenic infections. N Engl J Med (1970) 1.80
Serum complement component levels in human glomerulonephritis. Ann Intern Med (1971) 1.70
Immunology of sarcoidosis. Am J Med (1975) 1.69
Evidence for circulating immune complexes in sarcoidosis. Clin Exp Immunol (1974) 1.59
The effect of plasma upon lymphocyte response in vitro. Demonstration of a humoral inhibitor in patients with sarcoidosis. Clin Exp Immunol (1974) 1.51
Altered immunologic activity in sarcoidosis. Ann Intern Med (1966) 1.43
Lymphocyte subpopulations in sarcoidosis. Clin Exp Immunol (1974) 1.43
Immunologic components of hypersensitivity reactions to cromolyn sodium. N Engl J Med (1975) 1.42
The immunological competence of subjects with sarcoidosis. Clin Exp Immunol (1974) 1.26
Immunologic characterization of the mononuclear cell infiltrates in rheumatoid synovia, in rheumatoid nodules, and in lip biopsies from patients with Sjögren's syndrome. Arthritis Rheum (1975) 1.21
Culture of peripheral blood lymphocytes from sarcoidosis; response to mitogenic factor. Int Arch Allergy Appl Immunol (1971) 1.21
Lymphocyte response in sarcoidosis. Lancet (1972) 1.07
A correlation of in vivo delayed-type hypersensitivity with in vitro lymphocyte transformation in sarccidosis. Chest (1971) 1.01
Serum IgD concentrations in sarcoidosis and tuberculosis. Clin Exp Immunol (1972) 1.00
Effect of sera from patients with sarcoidosis on in vitro lymphocyte response. Int Arch Allergy Appl Immunol (1974) 1.00
In vitro observations on sarcoid lymphocytes and their correlation with cutaneous energy and clinical severity of disease. Am Rev Respir Dis (1973) 0.91
Monocyte receptor activity in normal individuals and patients with sarcoidosis. Immunol Commun (1972) 0.90
Atypical blood lymphocytes in sarcoidosis: morphology, cytochemistry, and membrane properties. Scand J Immunol (1974) 0.89
Immunological aspects of sarcoidosis. Scand J Respir Dis (1975) 0.87
EFFECT OF KVEIM ANTIGEN AND OLD TUBERCULIN ON LYMPHOCYTES IN CULTURE FROM SARCOID PATIENTS. Br Med J (1964) 0.87
Studies on the mechanism of lymphocyte transformation inhibition in sarcoidosis. Br J Dermatol (1969) 0.84
Serum IgE levels and reaginic-type skin reactions in sarcoidosis. Clin Exp Immunol (1975) 0.82
Correlation of phytohaemagglutinin-induced lymphocyte transformation with clinical manifestations of sarcoidosis. Acta Pathol Microbiol Scand B Microbiol Immunol (1974) 0.77
Standardization of bronchial inhalation challenge procedures. J Allergy Clin Immunol (1975) 10.52
Immunological studies concerning the nephritis of systemic lupus erythematosus. J Exp Med (1967) 10.22
Deoxybonucleic acid (DNA) and antibodies to DNA in the serum of patients with systemic lupus erythematosus. J Clin Invest (1966) 8.64
Measurement of serum DNA-binding activity in systemic lupus erythematosus. N Engl J Med (1969) 6.16
Immunologic factors and clinical activity in systemic lupus erythematosus. N Engl J Med (1968) 5.95
Reliability and validity of six systems for the clinical assessment of disease activity in systemic lupus erythematosus. Arthritis Rheum (1989) 4.02
Correlation between serum IgG-2 concentrations and the antibody response to bacterial polysaccharide antigens. N Engl J Med (1980) 3.95
An in vitro assay for cellular hypersensitivity in man. J Immunol (1970) 3.73
Mode of inheritance of decreased C3b receptors on erythrocytes of patients with systemic lupus erythematosus. N Engl J Med (1982) 3.40
Studies on mediator production by highly purified human T and B lymphocytes. J Exp Med (1974) 3.38
The pathogenesis of arthritis associated with viral hepatitis. Complement-component studies. N Engl J Med (1971) 3.31
Activation of the properdin pathway of complement in patients with gram-negative of bacteremia. N Engl J Med (1975) 2.63
Anticardiolipin antibodies and the risk for ischemic stroke and venous thrombosis. Ann Intern Med (1992) 2.63
Products of activated lymphocytes: leukocyte inhibitory factor (LIF) distinct from migration inhibitory factor (MIF). J Immunol (1974) 2.53
Cellular sensitivity to collagen in rheumatoid arthritis. N Engl J Med (1978) 2.50
Inherited deficiency of the second component of complement. Rheumatic disease associations. J Clin Invest (1976) 2.38
A computer based intervention to reduce unnecessary serologic testing. J Rheumatol (1999) 2.37
Clinical utility of the anti-CCP assay in patients with rheumatic diseases. Ann Rheum Dis (2003) 2.33
Metabolism of third complement component (C3) in nephritis. Involvement of the classic and alternate (properdin) pathways for complement activation. N Engl J Med (1972) 2.33
The compartmentalization of antigen-reactive lymphocytes in desensitized guinea pigs. J Exp Med (1971) 2.18
Fas ligand mutation in a patient with systemic lupus erythematosus and lymphoproliferative disease. J Clin Invest (1996) 2.07
Alterations in immunoregulatory T cell subsets in active systemic lupus erythematosus. J Clin Invest (1980) 2.06
Mediators of immunity: lymphokines and monokines. Adv Immunol (1980) 1.99
Interleukin 5 and phenotypically altered eosinophils in the blood of patients with the idiopathic hypereosinophilic syndrome. J Exp Med (1989) 1.97
Silicone breast implants and rheumatic disease. Clinical, immunologic, and epidemiologic studies. Arthritis Rheum (1994) 1.97
Modulation of cellular-immune responses in vivo and in vitro by histamine receptor-bearing lymphocytes. J Clin Invest (1976) 1.95
Immune complexes, complement, and anti-DNA in exacerbations of systemic lupus erythematosus (SLE). Medicine (Baltimore) (1981) 1.83
Production of migration inhibitory factor by non-dividing lymphocytes. J Immunol (1973) 1.82
Selective gamma-g globulin deficiencies in patients with recurrent pyogenic infections. N Engl J Med (1970) 1.80
Antibodies to ribonucleic acid in systemic lupus erythematosus. Proc Natl Acad Sci U S A (1969) 1.79
Complement in human disease. Annu Rev Med (1968) 1.79
Renal tubular acidosis, glomerulonephritis and immunologic factors in Sjögren's syndrome. Arthritis Rheum (1968) 1.72
Serum complement component levels in human glomerulonephritis. Ann Intern Med (1971) 1.70
A method for increasing the sensitivity of radial-immunodiffusion assay. Lancet (1970) 1.70
Maternal-fetal relation. Absence of an immunologic blocking factor from the serum of women with chronic abortions. N Engl J Med (1976) 1.69
Lymphocyte surface immunoglobulins. Distribution and frequency in lymphoproliferative diseases. N Engl J Med (1973) 1.69
Proteins phosphorylated during stress-induced apoptosis are common targets for autoantibody production in patients with systemic lupus erythematosus. J Exp Med (1997) 1.66
Immunologic studies of juvenile rheumatoid arthritis. Arthritis Rheum (1972) 1.65
Transfer of cellular hypersensitivity in chronic mucocutaneous candidiasis monitored in vivo and in vitro. Cell Immunol (1970) 1.64
Characterization of human migration inhibitory factor (MIF) from antigen-stimulated lymphocytes. Cell Immunol (1972) 1.63
Heavy chain subclass of human anti-platelet antibodies. Clin Immunol Immunopathol (1973) 1.61
Enzyme immunoassay for antibodies to native DNA. Specificity and quality of antibodies. Arthritis Rheum (1983) 1.56
Exercise-induced anaphylaxis. J Allergy Clin Immunol (1980) 1.54
Serum and synovial fluid IgG, IgA and IgM antigammaglobulins in rheumatoid arthritis. Arthritis Rheum (1972) 1.51
Clinical laboratory test findings in patients with chronic fatigue syndrome. Arch Intern Med (1995) 1.50
Hypocomplementemia in rheumatoid arthritis. Arthritis Rheum (1971) 1.48
Synthesis and release of leukotriene C4 by human eosinophils. J Immunol (1987) 1.47
The Guillain-Barré syndrome and multiple sclerosis. In vitro cellular responses to nervous-tissue antigens. N Engl J Med (1971) 1.47
Monoclonal anti-cardiolipin antibodies bind to DNA. Eur J Immunol (1984) 1.47
Complement components in synovial fluid: activation and fixation in seropositive rheumatoid arthritis. Ann N Y Acad Sci (1969) 1.46
IgG subclasses--a review. Ann Allergy (1987) 1.45
Tranexamic acid therapy in hereditary angioneurotic edema. N Engl J Med (1972) 1.44
Immunologic components of hypersensitivity reactions to cromolyn sodium. N Engl J Med (1975) 1.42
Immunoglobulin subclasses in normal children. Pediatr Res (1979) 1.42
Decreased expression of the C3b/C4b receptor (CR1) and the C3d receptor (CR2) on B lymphocytes and of CR1 on neutrophils of patients with systemic lupus erythematosus. Arthritis Rheum (1986) 1.41
Generation of antigen-specific suppressor cells during allergy desensitization. N Engl J Med (1980) 1.40
Immunological detection of nucleic acids and antibodies to nucleic acids and nuclear antigens by counterimmunoelectrophoresis. Clin Exp Immunol (1974) 1.39
C3b inactivator in the rheumatic diseases. Measurement by radial immunodiffusion and by inhibition of formation of properdin pathway C3 convertase. J Clin Invest (1976) 1.38
Adult Still's disease. Am J Med (1980) 1.38
Psoriatic arthritis: a clinical, immunologic and HLA study of 100 patients. Semin Arthritis Rheum (1979) 1.36
Human gamma-g subclasses. Prog Clin Immunol (1972) 1.35
A conserved idiotype and antibodies to retroviral proteins in systemic lupus erythematosus. J Clin Invest (1990) 1.35
Gamma G globulin subgroup composition of the glomerular deposits in human renal diseases. J Clin Invest (1970) 1.35
In vitro lymphocyte response of patients with immunologic deficiency diseases. N Engl J Med (1970) 1.34
Histamine-induced suppressor factor (HSF): further studies on the nature of the stimulus and the cell which produces it. Cell Immunol (1979) 1.33
Reference sera for antinuclear antibodies. I. Antibodies to native DNA, Sm, nuclear RNP, and SS-B/La. Arthritis Rheum (1982) 1.33
In vitro evidence for cellular hypersensitivity to glomerular-basement-membrane antigens in human glomerulonephritis. N Engl J Med (1970) 1.33
Correlation between G2m(n) immunoglobulin allotype and human antibody response and susceptibility to polysaccharide encapsulated bacteria. J Clin Invest (1985) 1.32
Immunobiology of the maternal-fetal relationship. Annu Rev Med (1979) 1.32
Studies of the antibodies in pemphigoid and pemphigus. J Lab Clin Med (1973) 1.31
pH gradient elution of human IgG1, IgG2 and IgG4 from protein A-sepharose. J Immunol Methods (1979) 1.31
Rheumatoid arthritis associated with eosinophilia. Ann Intern Med (1971) 1.29
The gammaG subclass of antinuclear and antinucleic acid antibodies. Arthritis Rheum (1972) 1.29
The natural history of exercise-induced anaphylaxis: survey results from a 10-year follow-up study. J Allergy Clin Immunol (1999) 1.29
Early-onset pauciarticular juvenile rheumatoid arthritis associated with human leukocyte antigen-DRw5, iritis, and antinuclear antibody. J Clin Invest (1980) 1.29
Hereditary C2 deficiency: diagnosis and HLA gene complex associations. J Immunol (1976) 1.28
Abdominal thrombotic and ischemic manifestations of the antiphospholipid antibody syndrome: CT findings in 42 patients. Radiology (2001) 1.27
Inherited deficiency of the sixth component of complement: a silent or null gene. J Immunol (1978) 1.27
Immunological properties of isolated IgG and IgM anti-gamma-globulins (rheumatoid factors). Clin Exp Immunol (1974) 1.26
Antibodies to DNA in patients with rheumatoid arthritis and juvenile rheumatoid arthritis. Arthritis Rheum (1976) 1.26
Human -fetoprotein. Isolation, characterization, and demonstration of microheterogeneity. J Biol Chem (1972) 1.26
Circulating anticoagulants to factor VIII. Immunochemical studies and clinical response to factor VIII concentrates. Am J Med (1970) 1.26
The influence of histamine on immune and inflammatory responses. Adv Immunol (1984) 1.25
Role of monosaccharides in the interaction of two lymphocyte mediators with their target cells. J Immunol (1976) 1.24
Characterization of the human blood lymphocytes that produce a histamine-induced suppressor factor (HSF). Cell Immunol (1980) 1.23
Mapping of the structural gene for the second component of complement with respect to the human major histocompatibility complex. Am J Hum Genet (1979) 1.22
Histamine-induced suppressor factor (HSF): effect on migration inhibitory factor (MIF) production and proliferation. J Immunol (1977) 1.21
Immunologic characterization of the mononuclear cell infiltrates in rheumatoid synovia, in rheumatoid nodules, and in lip biopsies from patients with Sjögren's syndrome. Arthritis Rheum (1975) 1.21
Antibodies to Sm and RNP. Prognosticators of disease involvement. Arthritis Rheum (1983) 1.21
Development of reticulum cell sarcoma during cyclophosphamide therapy. Arthritis Rheum (1974) 1.21
Cell-mediated immune response of ragweed-sensitive patients to ragweed antigen E. In vitro lymphocyte transformation and elaboration of lymphocyte mediators. J Clin Invest (1974) 1.21
Hemolytic assay of the ninth complement complement component: elevation and depletion in rheumatic diseases. J Exp Med (1971) 1.20
Re-examination of histocompatibility antigens found in patients with juvenile rheumatoid arthritis. N Engl J Med (1975) 1.20
Leukocyte inhibitory factor (LIF): production by purified human T and B lymphocytes. J Immunol (1975) 1.19
A controlled study of the prevalence of cognitive dysfunction in randomly selected patients with systemic lupus erythematosus. Arthritis Rheum (1992) 1.19
Antiphospholipid antibodies in systemic lupus erythematosus: evidence of an association with positive Coombs' and hypocomplementemia. J Rheumatol (1988) 1.18